Form 8K Tempest Therapeutics Inc For: 14 May
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tempest Therapeutics Inc (TPST)
Assess today's live Tempest Therapeutics Inc (TPST) share price, performance and insights using our live NASDAQ: TPST stock exchange data.
Analyse the historical data and Tempest Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Tempest Therapeutics share price buy/sell indicators using real-time data (or discuss the Tempest Therapeutics (TPST) stock price today with other investors in the Tempest Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TPST share price (ISIN: US87978U2078) to enhance your trading decisions with our free investment tools and resources.
What Is the Tempest Therapeutics Inc Share Price Today?
The Tempest Therapeutics share price today is 1.7400.
What Is the Stock Symbol for Tempest Therapeutics Inc
The stock symbol (or 'ticker') for Tempest Therapeutics Inc is "TPST."
What Stock Exchange Does Tempest Therapeutics Inc Trade On?
Tempest Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tempest Therapeutics Inc a Good Stock to Buy?
Determining whether Tempest Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Tempest Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Tempest Therapeutics share price buy/sell indicators using real-time data (or discuss the Tempest Therapeutics (TPST) stock price today with other investors in the Tempest Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TPST share price (ISIN: US87978U2078) to enhance your trading decisions with our free investment tools and resources.
What Is the Tempest Therapeutics Inc Share Price Today?
The Tempest Therapeutics share price today is 1.7400.
What Is the Stock Symbol for Tempest Therapeutics Inc
The stock symbol (or 'ticker') for Tempest Therapeutics Inc is "TPST."
What Stock Exchange Does Tempest Therapeutics Inc Trade On?
Tempest Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tempest Therapeutics Inc a Good Stock to Buy?
Determining whether Tempest Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
1.7400
-0.0400(-2.25%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.7400
1.8826
52 wk Range
1.5000
12.2300
TPST is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.74001.8826
52 wk Range
1.500012.2300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TPST Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
11.0000
Upside
+532.18%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
- Form 8K Tempest Therapeutics Inc For: 6 May
- Investing.com
- Form 13D/A Tempest Therapeutics For: 2 April
- Investing.com
- Form 8K Tempest Therapeutics Inc For: 14 May
- Investing.com
- Form 8K Tempest Therapeutics Inc For: 6 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.0000
(+532.18% Upside)
Earnings
Latest Release
14/05/2026
EPS / Forecast
-2.53 / -0.48
Revenue / Forecast
-- / --
Compare TPST to Peers and Sector
Metrics to compare | TPST | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTPSTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −3.1x | −0.5x | |
PEG Ratio | −0.01 | −0.01 | 0.00 | |
Price/Book | 31.1x | 2.4x | 2.6x | |
Price / LTM Sales | - | 111.8x | 3.1x | |
Upside (Analyst Target) | - | 94.1% | 55.1% | |
Fair Value Upside | Unlock | −3.8% | 7.2% | Unlock |
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Tempest Therapeutics (NASDAQ: TPST) Share Price Today?
The Tempest Therapeutics stock price today is 1.7400 USD.
What Stock Exchange Does Tempest Therapeutics (TPST) Trade On?
Tempest Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Tempest Therapeutics?
The stock symbol (also called a 'ticker') for Tempest Therapeutics is "TPST."
What Is the Current Tempest Therapeutics Market Capitalisation?
As of today, Tempest Therapeutics (NASDAQ: TPST) market cap is 25.2000M USD.
What Is Tempest Therapeutics's (TPST) Earnings Per Share (TTM)?
The Tempest Therapeutics EPS is currently -7.1553 (Trailing Twelve Months).
Is TPST a Buy or Sell From a Technical Analyst Perspective?
Based on today's Tempest Therapeutics moving averages and other technical indicators, the daily buy/sell signal for TPST stock is Strong Sell.
How Many Times Has Tempest Therapeutics Stock Split?
Tempest Therapeutics has split 3 times. (See the TPST stock split history page for full effective split date and price information.)
How Many Employees Does Tempest Therapeutics Have?
Tempest Therapeutics has 4 employees, based on their latest Companies House report.
What is the current trading status of Tempest Therapeutics (NASDAQ: TPST)?
As of 20/05/2026, Tempest Therapeutics (TPST) is trading at a share price of 1.7400 USD, with a previous close of 1.7800 USD. The stock has fluctuated within a day range of 1.7400 USD to 1.8826 USD, while its 52-week range spans from 1.5000 USD to 12.2300 USD.
What Is Tempest Therapeutics (TPST) Price Target According to Analysts?
The average 12-month price target for Tempest Therapeutics is 11.0000 USD, with a high estimate of 11 USD and a low estimate of 11 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +532.18% Upside potential.
What Is the TPST Premarket Price?
TPST's last pre-market stock price is 1.8015 USD. The pre-market share volume is 410.0000, and the stock has decreased by 0.0215, or 1.2100%.
What Is the TPST After Hours Price?
TPST's last after hours stock price is 1.8400 USD, the stock has decreased by 0.0600, or 3.3700%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.